SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-19-005503
Filing Date
2019-05-09
Accepted
2019-05-09 09:28:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 azrx424b5_may92019.htm 424B5 464974
2 IMAGE ac_logo.jpg GRAPHIC 9614
3 IMAGE azrx.jpg GRAPHIC 9053
  Complete submission text file 0001654954-19-005503.txt   491994
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B5 | Act: 33 | File No.: 333-226065 | Film No.: 19809077
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1